Inhibitory role of diazepam on autoimmune inflammation in rats with experimental autoimmune encephalomyelitis

Neuroscience

Volumn 199, Issue , 2011, Pages 421-428

  Bibolini, M J ^a   Chanaday, N L ^a   Baez N S ^a   Degano, A L ^a   Monferran, C G ^a   Roth, G A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Autoimmunity; Diazepam; GABAergic system; Multiple sclerosis; Neurotransmitter release

Indexed keywords

4 AMINOBUTYRIC ACID; DIAZEPAM; GLUTAMIC ACID; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; FRONTAL CORTEX; GABAERGIC SYSTEM; HISTOPATHOLOGY; INCIDENCE; MONONUCLEAR CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SYNAPTOSOME; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNITY; DIAZEPAM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GABA AGONISTS; INFLAMMATION; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

EID: 83055194306     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.08.076     Document Type: Article

References (31)

1. Study R.E., Barker J.L. Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 1981, 78:7180-7184.
2. Bhat R., Axtell R., Mitra A., Miranda M., Lock C., Tsien R.W., Steinman L. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 2010, 107:2580-2585.
3. Bolton C., Paul C. Glutamate receptors in neuroinflammatory demyelinating disease. Mediators Inflamm ID 2006, 93684:1-12.
4. Centonze D., Muzio L., Rossi S., Furlan R., Bernardi G., Martino G. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 2010, 17:1083-1091.
5. Cid M.P., Vilcaes A.A., Rupil L.L., Salvatierra N.A., Roth G.A. Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis. Neuroscience 2011, 189:337-344.
6. Cua D.J., Hinton D.R., Kirkman L., Stohlman S.A. Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice. Eur J Immunol 1995, 25:2318-2324.
7. Degano A.L., Ditamo Y., Roth G.A. Neuronal antigens modulate the immune response associated with experimental autoimmune encephalomyelitis. Immunol Cell Biol 2004, 82:17-23.
8. Degano A.L., Roth G.A. Passive transfer of experimental autoimmune encephalomyelitis in Wistar rats: dissociation of clinical symptoms and biochemical alterations. J Neurosci Res 2000, 59:283-290.
9. Demakova E.V., Korobov V.P., Lemkina L.M. Determination of gamma-aminobutyric acid concentration and activity of glutamate decarboxylase in blood serum of patients with multiple sclerosis. Klin Lab Diagn 2003, 4:15-17.
10. Drugan R.C., Holmes P.V. Central and peripheral benzodiazepine receptors: involvement in an organism's response to physical and psychological stress. Neurosci Biobehav Rev 1991, 15:277-298.
11. Dutta R., Trapp B.D. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 2011, 93:1-12.
12. Gottesfeld Z., Teitelbaum D., Webb C., Arnon R. Changes in the GABA system in experimental allergic encephalomyelitis-induced paralysis. J Neurochem 1976, 27:695-699.
13. Huang Z.J. Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond. J Physiol 2009, 587:1881-1888.
14. Ludwin S.K. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies. J Neuropathol Exp Neurol 2006, 65:305-318.
15. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007, 8:913-919.
16. Mosmann T.R., Sad S. The expanding universe of T-cells subsets: Th1, Th2 and more. Immunol Today 1996, 17:138-146.
17. Núñez-Iglesias M.J., Novío S., Almeida-Dias A., Freire-Garabal M. Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats. Pharmacol Biochem Behav 2010, 97:350-356.
18. Pedotti R., De Voss J.J., Steinman L., Galli S.J. Involvement of both allergic and autoimmune mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol 2003, 9:479-484.
19. Rivero V.E., Riera C.M., Roth G.A. Humoral response against myelin antigens in two strains of rats with different susceptibility to experimental allergic encephalomyelitis (EAE). Autoimmunity 1999, 29:129-137.
20. Roth G.A., Obata K. Experimental allergic encephalomyelitis: dissociation of immunochemical and clinico-pathological responses in two strains of rats. Neurochem Int 1991, 19:213-220.
21. Scerbo M.J., Rupil L.L., Bibolini M.J., Roth G.A., Monferran C.G. Protective effect of a synapsin peptide genetically fused to the B subunit of Escherichia coli heat-labile enterotoxin in rat autoimmune encephalomyelitis. J Neurosci Res 2009, 87:2273-2281.
22. 2+ entry preferentially effects protein dephosphorylation, phosphorylarion, and glutamate release. J Biol Chem 1992, 267:1983-1989.
23. Slavin D.A., Bucher A.E., Degano A.L., Soria N.W., Roth G.A. Time course of biochemical and immunohistological alterations during experimental allergic encephalomyelitis. Neurochem Int 1996, 29:597-605.
24. Staykova M.A., Cowden W.B., Willenborg D.O. Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation. Immunol Cell Biol 2002, 80:188-197.
25. Tian J., Lu Y., Zhang H., Chau C.H., Dang H.N., Kaufman D.L. γ-Aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 2004, 173:5298-5304.
26. 2+ and glutamate release. J Neurochem 1989, 53:1693-1699.
27. Trapp B., Nave K.-A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 2008, 31:247-269.
28. Vercellino M., Merola A., Piacentino C., Votta B., Capello E., Mancardi G.L., Mutani R., Giordana M.T., Cavalla P. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 2007, 66:732-739.
29. Vereker E., O'Donnell E., Lynch M.A. The inhibitory effect of interleukin-1β on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 2000, 20:6811-6819.
30. 2+-dependent glutamate release in cerebral cortex synaptosomes of rats with experimental autoimmune encephalomyelitis. J Neurochem 2009, 108:881-890.
31. A receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci 2007, 27:7520-7531.